Ashley L. Eheim
Berlin, BE 13342, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Identification of Small Molecules that Modulate Mutant p53 Condensation.
Journal: iScience
Published: April 30, 2020
Characterization of the Menin-MLL Interaction as Therapeutic Cancer Target.
Journal: Cancers
Published: December 12, 2019
Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles.
Journal: Nature chemical biology
Published: August 20, 2019
Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia.
Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia.
Journal: Journal of hematology & oncology
Published: March 29, 2019
The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies.
Journal: Leukemia
Published: October 25, 2018
Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of Resistance.
Journal: Molecular cancer therapeutics
Published: December 18, 2017
Novel Class of Potent and Cellularly Active Inhibitors Devalidates MTH1 as Broad-Spectrum Cancer Target.
Journal: ACS chemical biology
Published: July 06, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026